HIV algorithm

David A. Sadler 73507.2225 at
Tue Mar 26 08:45:11 EST 1996

Hello, Everyone:

I realize that strategies for therapy and monitoring disease in HIV infection is
in a state of flux, but I have been asked to develop an algorithm for an HMO,
and I wonder if the NIH panel recommendations of a few years ago are still
timely.  Are decision points for treatment and monitoring still focus on CD4
counts of 500/ul and 200/ul for anti-retroviral and  PCP prophylaxis,
respectively?  Any recent references would be appreciated.

D.A.Sadler, MD

More information about the Cytometry mailing list